Sign Up to like & get
recommendations!
1
Published in 2017 at "Diabetes Care"
DOI: 10.2337/dc16-2602
Abstract: Glucagon-like peptide 1 agonists such as exenatide have been reported to improve fasting and postprandial lipid profiles and cardiovascular outcomes in patients with type 2 diabetes but to have minimal effects on fasting profiles in…
read more here.
Keywords:
patients type;
exenatide improves;
type diabetes;
hdl particle ... See more keywords